PortfoliosLab logoPortfoliosLab logo
IDYA vs. IR
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

IDYA vs. IR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in IDEAYA Biosciences, Inc. (IDYA) and Ingersoll-Rand Plc (IR). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, IDYA achieves a -0.98% return, which is significantly higher than IR's -3.21% return.


IDYA

1D
9.61%
1M
17.63%
YTD
-0.98%
6M
-3.58%
1Y
57.96%
3Y*
11.82%
5Y*
9.49%
10Y*

IR

1D
-1.58%
1M
8.08%
YTD
-3.21%
6M
-5.86%
1Y
-6.36%
3Y*
6.65%
5Y*
10.10%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

IDYA vs. IR - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
IDYA
IDEAYA Biosciences, Inc.
-0.98%34.51%-27.77%95.82%-23.14%68.86%86.67%-46.43%
IR
Ingersoll-Rand Plc
-3.21%-12.34%17.06%48.21%-15.41%35.85%24.21%8.31%

Correlation

The correlation between IDYA and IR is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.21

Correlation (3Y)
Calculated over the trailing 3-year period

0.30

Correlation (5Y)
Calculated over the trailing 5-year period

0.28

Correlation (All Time)
Calculated using the full available price history since May 23, 2019

0.23

Fundamentals

EPS

IDYA:

-$1.58

IR:

$1.96

PS Ratio

IDYA:

13.50

IR:

2.95

Total Revenue (TTM)

IDYA:

$225.27M

IR:

$7.78B

Gross Profit (TTM)

IDYA:

$215.25M

IR:

$2.98B

EBITDA (TTM)

IDYA:

-$157.90M

IR:

$1.55B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

IDYA vs. IR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IDYA
IDYA Risk / Return Rank: 7575
Overall Rank
IDYA Sharpe Ratio Rank: 7777
Sharpe Ratio Rank
IDYA Sortino Ratio Rank: 7373
Sortino Ratio Rank
IDYA Omega Ratio Rank: 7272
Omega Ratio Rank
IDYA Calmar Ratio Rank: 7777
Calmar Ratio Rank
IDYA Martin Ratio Rank: 7575
Martin Ratio Rank

IR
IR Risk / Return Rank: 3333
Overall Rank
IR Sharpe Ratio Rank: 3535
Sharpe Ratio Rank
IR Sortino Ratio Rank: 3131
Sortino Ratio Rank
IR Omega Ratio Rank: 3030
Omega Ratio Rank
IR Calmar Ratio Rank: 3636
Calmar Ratio Rank
IR Martin Ratio Rank: 3434
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IDYA vs. IR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for IDEAYA Biosciences, Inc. (IDYA) and Ingersoll-Rand Plc (IR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


IDYAIRDifference
Sharpe ratioReturn per unit of total volatility

+1.37

Sortino ratioReturn per unit of downside risk

+1.88

Omega ratioGain probability vs. loss probability

1.23

1.00

+0.23

Calmar ratioReturn relative to maximum drawdown

2.15

-0.21

+2.36

Martin ratioReturn relative to average drawdown

4.76

-0.46

+5.22

IDYA vs. IR - Sharpe Ratio Comparison

The current IDYA Sharpe Ratio is 1.18, which is higher than the IR Sharpe Ratio of -0.19. The chart below compares the historical Sharpe Ratios of IDYA and IR, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

IDYA vs. IR - Drawdown Comparison

The maximum IDYA drawdown since its inception was -78.36%, which is greater than IR's maximum drawdown of -50.27%. Use the drawdown chart below to compare losses from any high point for IDYA and IR.


Loading charts...

Drawdown Indicators


IDYAIRDifference

Max Drawdown

Largest peak-to-trough decline

-78.36%

-50.27%

-28.09%

Max Drawdown (1Y)

Largest decline over 1 year

-27.10%

-30.56%

+3.46%

Max Drawdown (3Y)

Largest decline over 3 years

-69.23%

-36.62%

-32.61%

Max Drawdown (5Y)

Largest decline over 5 years

-69.42%

-36.62%

-32.80%

Current Drawdown

Current decline from peak

-27.37%

-27.14%

-0.23%

Average Drawdown

Average peak-to-trough decline

-32.37%

-12.87%

-19.50%

Ulcer Index

Depth and duration of drawdowns from previous peaks

12.22%

13.91%

-1.69%

Volatility

IDYA vs. IR - Volatility Comparison

IDEAYA Biosciences, Inc. (IDYA) has a higher volatility of 20.73% compared to Ingersoll-Rand Plc (IR) at 9.65%. This indicates that IDYA's price experiences larger fluctuations and is considered to be riskier than IR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


IDYAIRDifference

Volatility (1M)

Calculated over the trailing 1-month period

20.73%

9.65%

+11.08%

Volatility (6M)

Calculated over the trailing 6-month period

35.84%

25.65%

+10.19%

Volatility (1Y)

Calculated over the trailing 1-year period

49.32%

33.67%

+15.65%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

59.41%

30.11%

+29.30%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

74.34%

34.35%

+39.99%

Dividends

IDYA vs. IR - Dividend Comparison

IDYA has not paid dividends to shareholders, while IR's dividend yield for the trailing twelve months is around 0.10%.


PositionTTM2025202420232022202120202019
IDYA
IDEAYA Biosciences, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
IR
Ingersoll-Rand Plc
0.10%0.10%0.09%0.10%0.15%0.03%0.00%5.78%

Financials

IDYA vs. IR - Financials Comparison

This section allows you to compare key financial metrics between IDEAYA Biosciences, Inc. and Ingersoll-Rand Plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00500.00M1.00B1.50B2.00B20222023202420252026
6.56M
1.85B
(IDYA) Total Revenue
(IR) Total Revenue
Values in USD except per share items

Frequently Asked Questions


IDYA and IR have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

IDYA has higher volatility (20.73%) compared to IR (9.65%). In terms of maximum drawdown, IDYA dropped -78.36% vs IR's -50.27%.

IDYA currently has the higher Sharpe Ratio (1.18 vs -0.19), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for IDYA and IR

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer